New Paper - Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

Speaker

David Binder, Graduate Student, Schreiber Lab

Date

September 14, 2011, 1:00 pm – 2:00 pm

Location

GCIS
W301

Description

CABI-JC New Paper - Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

Submitting Unit: Committee on Cancer Biology
Type of Event: Journal Club
Date of Event: Wednesday, September 14 2011
Start Time: 12:00 PM
End Time: 1:00 PM
Building: Gordon Center for Integrative Science, Room W301

Name of Series, Lectureship, Ceremony:
CCB Journal Club

Title of talk or presentation:
New Paper - Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

Speaker’s Name and Degrees:
David Binder, Graduate Student, Schreiber Lab

Speaker’s Institutional Affiliation:
UChicago

Description:
COMMITTEE ON CANCER BIOLOGY
JOURNAL CLUB

Wednesday, September 14th , 2011
GCIS W301
12:00pm - 1:00pm

Chimeric Antigen Receptor–Modified
T Cells in Chronic Lymphoid Leukemia

David L. Porter, M.D., Bruce L. Levine, Ph.D., Michael Kalos, Ph.D.,
Adam Bagg, M.D., and Carl H. June, M.D.
N Engl J Med 2011;365:725-33.

Presented By:
David Binder, Graduate Student
Committee on Cancer Biology
Schreiber Laboratory

~ Copies of the paper will be available ~


Contact Name
Biomedical Sciences Cluster

Contact Email
beaudreau@bsd.uchicago.edu

Contact Phone
2-1857

Latest News

Start-up founded by IGSB faculty wins $250,000 Polsky Center award

BiomeSense, a startup developing biosensors that can detect particular kinds of bacteria in patients’ feces that could help improve the efficacy of clinical trials, won the University of Chicago’s Innovation Fund finals and an investment of up to $250,000 from the college.

Massive data analysis shows what drives the spread of flu in the US

Models built with data from health claims, weather, geography and Twitter predict how the flu spreads from the south and southeastern coast

Subscribe to RSS Feed